Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Neurochemistry|December 1, 1998
Characterization of (2S,2'R,3'R)-2-(2',3'-[3H]-dicarboxycyclopropyl)glycine binding in rat brainV Mutel, G Adam, S Chaboz, et al.
Neuropharmacology|July 8, 2000
Characterization of [(3)H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using semliki forest virus vectorsC Schweitzer, C Kratzeisen, G Adam, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 26, 1998
Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in ratsF Jenck, J L Moreau, H H Berendsen, et al.
Environmental Research|September 29, 2009
Increased micronuclei and bulky DNA adducts in cord blood after maternal exposures to traffic-related air pollutionM Pedersen, J Wichmann, H Autrup, et al.
British Journal of Pharmacology|March 21, 1998
Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranesJ Cartmell, G Adam, S Chaboz, et al.
Brain Research|June 19, 1998
Effect of metabotropic glutamate receptor activation on receptor-mediated cyclic AMP responses in primary cultures of rat striatal neuronesJ Cartmell, F Goepfert, F Knoflach, et al.
The European Journal of Neuroscience|March 22, 2002
A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memoryG A Higgins, J N C Kew, J G Richards, et al.
Neuropharmacology|July 11, 2001
Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological functionG A Higgins, A J Grottick, T M Ballard, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2000
A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the ratF Jenck, J Wichmann, F M Dautzenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
5-HT2C receptor agonists: pharmacological characteristics and therapeutic potentialJ R Martin, M Bös, F Jenck, et al.
Pageof 6